PBLS — Parabilis Medicines, Inc.

Nasdaq · Health Care · Pharmaceuticals · CIK 1657677 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 0 -47,453,000 -45,316,000 384,173,000 329,039,000 139,953,000
Mar 2025 0 -40,241,000 -38,326,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-83,354,000
Investing CF
$6,320,000
Financing CF
$418,186,000
CapEx
$-443,000
Dividends Paid
Buybacks
EPS Diluted TTM
As of
2026-06-11

Balance + Analyst (yfinance extras)

Retained Earnings
$-586,820,000
Inventory
Receivables
ST Investments
EBIT TTM
$-82,951,000
Pretax Income TTM
$-83,642,000
Interest Exp TTM
$691,000
Analysts

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 0 -152,079,000 -145,889,000 80,820,000 97,344,000 -123,713,000
Dec 2024 0 -126,125,000 -117,914,000 149,253,000 92,814,000 -103,613,000

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.01T $1133.00
JNJ JOHNSON & JOHNSON $579.83B $240.87
ABBV AbbVie Inc. $402.35B $227.73
MRK Merck & Co., Inc. $294.03B $119.05
NVS NOVARTIS AG $292.07B $153.07

News headlines (Yahoo Finance, 1h cache)

Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
2026-06-11 20:05 · Yahoo
How to Play PBLS Stock After the Parabilis IPO
2026-06-11 19:12 · Yahoo
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering
2026-06-10 00:22 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.